Jonathan Edward Millar
Impact in
- Infectious Diseases top 0.2%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Genetics top 5%
- Genetic Associations and Epidemiology
Papers in
-
- COVID-19 Clinical Research Studies 19
-
- Respiratory Support and Mechanisms 17
- Co-authors
- John Kenneth Baillie (7 shared papers)Clark D Russell (4 shared papers)Daniel Francis McAuley (13 shared papers)John Francis Fraser (22 shared papers)Jonathon Paul Fanning (6 shared papers)Charles I. McDonald (2 shared papers)Jacky Yung Suen (16 shared papers)Maximilian Valentin Malfertheiner (11 shared papers)
- Journals
- The Lancet (8 papers)Critical Care (6 papers)Nature (4 papers)Perfusion (4 papers)Intensive Care Medicine Experimental (4 papers)
- Partner nations
- United KingdomAustraliaGermany
In The Last Decade
Jonathan Edward Millar
72 papers receiving 8.1k citations
Jonathan Edward Millar's Hit Papers
Peers
Comparison fields: 5 of 119
- Infectious Diseases 3.5k
- Genetics 466
- Applied Microbiology and Biotechnology 34
- Pulmonary and Respiratory Medicine 501
- Biomedical Engineering 477
Countries citing papers authored by Jonathan Edward Millar
This map shows the geographic impact of Jonathan Edward Millar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan Edward Millar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan Edward Millar more than expected).
Fields of papers citing papers by Jonathan Edward Millar
This network shows the impact of papers produced by Jonathan Edward Millar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan Edward Millar. The network helps show where Jonathan Edward Millar may publish in the future.
Co-authors
The 25 scholars most cited alongside Jonathan Edward Millar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 74 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury Hit paper breakdown → | 2020 | 1572 |
| 2 | Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2021 | 1531 |
| 3 | Genetic mechanisms of critical illness in COVID-19 Hit paper breakdown → | 2020 | 1024 |
| 4 | Mapping the human genetic architecture of COVID-19 Hit paper breakdown → | 2021 | 656 |
| 5 | The inflammatory response to extracorporeal membrane oxygenation (ECMO): a review of the pathophysiology Hit paper breakdown → | 2016 | 596 |
| 6 | Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2021 | 411 |
| 7 | Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial Hit paper breakdown → | 2021 | 393 |
| 8 | Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2022 | 282 |
| 9 | Whole-genome sequencing reveals host factors underlying critical COVID-19 Hit paper breakdown → | 2022 | 233 |
| 10 | Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis Hit paper breakdown → | 2022 | 231 |
| 11 | 2021 | 213 | |
| 12 | 2021 | 142 | |
| 13 | GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19 Hit paper breakdown → | 2023 | 125 |
| 14 | 2023 | 84 | |
| 15 | 2014 | 68 | |
| 16 | 2019 | 61 | |
| 17 | 2014 | 57 | |
| 18 | 2020 | 47 | |
| 19 | 2021 | 43 | |
| 20 | 2021 | 36 |
About Jonathan Edward Millar
Jonathan Edward Millar is a scholar working on Infectious Diseases, Pulmonary and Respiratory Medicine, Biomedical Engineering, Anesthesiology and Pain Medicine and Genetics, having authored 74 papers that have together received 8.4k indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (19 papers), Respiratory Support and Mechanisms (17 papers), Mechanical Circulatory Support Devices (11 papers), Genetic Associations and Epidemiology (6 papers), Anesthesia and Sedative Agents (3 papers), Transplantation: Methods and Outcomes (3 papers), Mesenchymal stem cell research (2 papers) and Emergency and Acute Care Studies (1 paper). The work is most often cited by research in Infectious Diseases (3.5k citations), Genetics (466 citations), Applied Microbiology and Biotechnology (34 citations), Pulmonary and Respiratory Medicine (501 citations) and Biomedical Engineering (477 citations). Jonathan Edward Millar has collaborated with scholars based in United Kingdom, Australia and Germany. Frequent co-authors include John Kenneth Baillie, Clark D Russell, Daniel Francis McAuley, John Francis Fraser, Jonathon Paul Fanning, Charles I. McDonald, Jacky Yung Suen, Maximilian Valentin Malfertheiner, Katrina K. Ki and Margaret R. Passmore. Their work appears in journals such as The Lancet, Critical Care, Nature, Perfusion and Intensive Care Medicine Experimental.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.